DLVR eVLPs: A Promising Platform for In Vivo Delivery of Gene Editors
Time: 9:00 am
day: Day One AM
Details:
- The role of in vivo delivery technology in enabling gene editing and the barriers that remain
- DLVR platform: engineered viral-like particles (eVLPs) and their advantages in in vivo gene editing
- Assess how platform engineering is essential to streamlining the development of DLVR technology
